Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Bryon A. Tompkins,Darcy L. DiFede,Aisha Khan,Ana Marie Landin,Ivonne Hernandez Schulman,Marietsy V. Pujol,Alan W. Heldman,Roberto Miki,Pascal J. Goldschmidt-Clermont,Bradley J. Goldstein,Muzammil Mushtaq, Silvina Levis-Dusseau,John J. Byrnes,Maureen Lowery,Makoto Natsumeda,Cindy Delgado,Russell Saltzman,Mayra Vidro-Casiano, Moisaniel Da Fonseca,Samuel Golpanian,Courtney Premer,Audrey Medina,Krystalenia Valasaki,Victoria Florea,Erica Anderson,Jill El-Khorazaty,Adam Mendizabal,Geoff Green,Anthony A. Oliva,Joshua M. Hare The Journals of Gerontology Series A（2017）
Key words
Immunomodulation,Tumor necrosis factor-alpha,Regenerative medicine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper